SEC Form 4 · accession 0001127602-17-031737
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Luke A Pomilio
Officer — EVP, Finance & CFO
Period of report
Nov 7, 2017
Accepted (ET)
Nov 9, 2017 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 7, 2017 | S | 1,900 | $50.82 | D | 45,486 | D | |
| Common StockF2 | Nov 7, 2017 | S | 10,529 | $50.60 | D | 34,957 | D | |
| Common StockF3 | Nov 8, 2017 | S | 12,934 | $50.77 | D | 22,023 | D | |
| Common StockF4 | Nov 9, 2017 | S | 4,000 | $50.70 | D | 18,023 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.59 to $50.99. Full information regarding the number of shares sold at each separate price will be provided upon the request of the commission staff, ConMed, or a ConMed security holder.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.50 to $50.72. Full information regarding the number of shares sold at each separate price will be provided upon the request of the commission staff, ConMed, or a ConMed security holder.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.54 to $51.14. Full information regarding the number of shares sold at each separate price will be provided upon the request of the commission staff, ConMed, or a ConMed security holder.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.65 to $50.75. Full information regarding the number of shares sold at each separate price will be provided upon the request of the commission staff, ConMed, or a ConMed security holder.